Publications by authors named "David Brayden"

Claim this Profile
C
Capryol® 90 is an efficacious intestinal absorption enhancer for insulin in vivo when combined other excipients.
Fiona McCartney, Philippe Caisse, Camille Dumont, David J Brayden

Int J Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oromucosal films for peptide delivery: formulation strategies using permeation enhancers and polymers.
Sandeep Karki, Sahil Malhotra, Muhammad Ijaz, Eoin D O'Cearbhaill, Line Hagner Nielsen, David J Brayden

Drug Deliv Transl Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solidified ionic liquid-based formulations of metformin with enhanced GI epithelial permeability.
Evangelia Tsolaki, Fiona McCartney, Anne Marie Healy, David J Brayden, Steven Ferguson

Int J Pharm· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Devices to overcome the buccal mucosal barrier to administer therapeutic peptides.
Sahil Malhotra, Thomas Lijnse, Eoin O' Cearbhaill, David J Brayden

Adv Drug Deliv Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Albumin-based delivery systems: Recent advances, challenges, and opportunities.
Gillian Murphy, David J Brayden, David L Cheung, Aaron Liew, Michael Fitzgerald

J Control Release· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease.
Wunan Zhang, Fiona McCartney, Yining Xu, Cécilia Bohns Michalowski, Inês Domingues, David J Brayden

J Control Release· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Labrafac MC60 is an efficacious intestinal permeation enhancer for macromolecules: Comparisons with Labrasol® ALF in ex vivo and in vivo rat studies.
Fiona McCartney, Philippe Caisse, Camille Dumont, David J Brayden

Int J Pharm· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays" [European Journal of Pharmaceutical Sciences 159 (2021) 105737].
David J Brayden, Vivien Stuettgen

Eur J Pharm Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducible Synthesis of Biocompatible Albumin Nanoparticles Designed for Intra-articular Administration of Celecoxib to Treat Osteoarthritis.
Rumi Khandelia, Tom Hodgkinson, Daniel Crean, Dermot F Brougham, Dimitri Scholz, David J Brayden

ACS Appl Mater Interfaces· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of surfactant excipients in oral drug formulations.
Sam Maher, Caroline Geoghegan, David J Brayden

Adv Drug Deliv Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Buccal delivery of small molecules and biologics: Of mucoadhesive polymers, films, and nanoparticles - An update.
Varsha V Nair, Pablo Cabrera, Constanza Ramírez-Lecaros, Miguel O Jara, David J Brayden

Int J Pharm· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Selenomethionine Entrapped in Nanoparticles for Oral Supplementation Using In Vitro, Ex Vivo and In Vivo Models.
Shane Forde, Giulianna Vozza, David J Brayden, Hugh J Byrne, Jesus M Frías

Molecules· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localised Delivery of Macromolecules to the Large Intestine: Translation to Clinical Trials.
David J Brayden

BioDrugs· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C) and salcaprozate sodium (SNAC).
Caroline Twarog, Elias Fattal, Magali Noiray, Brigitte Illel, David J Brayden

Int J Pharm· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat.
Patrik Lundquist, Georgiy Khodus, Zhigao Niu, Lungile Nomcebo Thwala, Fiona McCartney, David J Brayden

ACS Nano· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation, Characterisation and Evaluation of the Antihypertensive Peptides, Isoleucine-Proline-Proline and Leucine-Lysine-Proline in Chitosan Nanoparticles Coated with Zein for Oral Drug Delivery.
Minna Khalid Danish, John P Gleeson, David J Brayden, Hugh J Byrne, Jesus M Frías

Int J Mol Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development.
Marilyn N Martinez, Fang Wu, Balint Sinko, David J Brayden, Michael Grass

AAPS J· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Mucoadhesion and In Vitro Intestinal Permeability of Mannosylated Chitosan Nanocarriers.
Sadaf Ejaz, Bridget Hogg, Delyan R Hristov, David J Brayden, Muhammad Imran

Pharmaceutics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Neha Shrestha, Yining Xu, Julien R C Prévost, Fiona McCartney, David Brayden

Acta Biomater· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review.
Joseph P O'Shea, Patrick Augustijns, Martin Brandl, David J Brayden, Joachim Brouwers

Eur J Pharm Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the oral bioavailability of protein hydrolysates derived from food sources: A critical review of current bioassays.
Muhammad Mustafa Abeer, Sanja Trajkovic, David J Brayden

Biomed Pharmacother· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient Permeation Enhancer® (TPE®) technology for oral delivery of octreotide: a technological evaluation.
David J Brayden, Sam Maher

Expert Opin Drug Deliv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation strategies to improve the efficacy of intestinal permeation enhancers.
Sam Maher, David J Brayden

Adv Drug Deliv Rev· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entrapment of Hydrophilic and Hydrophobic Molecules in Beads Prepared from Isolated Denatured Whey Protein.
Joanne Heade, Robert Kent, Sinead B Bleiel, David J Brayden

Pharmaceutics· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and In Vivo Evaluation of Insulin-Loaded Whey Beads as an Oral Peptide Delivery System.
Joanne Heade, Fiona McCartney, Miguel Chenlo, Olga Moreno Marro, Maja Severic, David J Brayden

Pharmaceutics· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis